{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:17Z","timestamp":1787032817379,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,27]]},"DOI":"10.7759\/cureus.19076","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T09:29:35Z","timestamp":1635326975000},"source":"Crossref","is-referenced-by-count":4,"title":["A Dive Into Oliceridine and Its Novel Mechanism of Action"],"prefix":"10.7759","author":[{"given":"Anjali","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germin","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A","family":"Brust-Sisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.4103\/2231-4040.72250","article-title":"Clinical aspects of acute post-operative pain management & its assessment","volume":"1","author":"Gupta A","year":"2010","unstructured":"Gupta A, Kaur K, Sharma S, Goyal S, Arora S, Murthy RS. Clinical aspects of acute post-operative pain management & its assessment. J Adv Pharm Technol Res. 2010, 1:97-108.","journal-title":"J Adv Pharm Technol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.12.008","article-title":"Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council","volume":"17","author":"Chou R","year":"2016","unstructured":"Chou R, Gordon DB, de Leon-Casasola OA, et al.. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016, 17:131-57. 10.1016\/j.jpain.2015.12.008","journal-title":"J Pain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg497","article-title":"The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors","volume":"42 Suppl 3","author":"Stephens J","year":"2003","unstructured":"Stephens J, Laskin B, Pashos C, Pe\u00f1a B, Wong J. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors. Rheumatology (Oxford). 2003, 42 Suppl 3:iii40-52. 10.1093\/rheumatology\/keg497","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S144066","article-title":"Poorly controlled postoperative pain: prevalence, consequences, and prevention","volume":"10","author":"Gan TJ","year":"2017","unstructured":"Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017, 10:2287-98. 10.2147\/JPR.S144066","journal-title":"J Pain Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cps.2019.12.005","article-title":"The opioid epidemic","volume":"47","author":"Upp LA","year":"2020","unstructured":"Upp LA, Waljee JF. The opioid epidemic. Clin Plast Surg. 2020, 47:181-90. 10.1016\/j.cps.2019.12.005","journal-title":"Clin Plast Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-99124-5_214","article-title":"The epidemiology of inadequate control of acute pain","author":"Williamson KJ","year":"2019","unstructured":"Williamson KJ, Stram ML. The epidemiology of inadequate control of acute pain. Pain. Abd-Elsayed A (ed): Springer, Cham; 2019. 1005-7. 10.1007\/978-3-319-99124-5_214"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S217563","article-title":"ATHENA: a phase 3, open-label study of the safety and effectiveness of oliceridine (TRV130), a G-protein selective agonist at the \u00b5-opioid receptor, in patients with moderate to severe acute pain requiring parenteral opioid therapy","volume":"12","author":"Bergese SD","year":"2019","unstructured":"Bergese SD, Brzezinski M, Hammer GB, et al.. ATHENA: a phase 3, open-label study of the safety and effectiveness of oliceridine (TRV130), a G-protein selective agonist at the \u00b5-opioid receptor, in patients with moderate to severe acute pain requiring parenteral opioid therapy. J Pain Res. 2019, 12:3113-26. 10.2147\/JPR.S217563","journal-title":"J Pain Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2156","article-title":"Outpatient opioid prescriptions for children and opioid-related adverse events","volume":"142","author":"Chung CP","year":"2018","unstructured":"Chung CP, Callahan ST, Cooper WO, et al.. Outpatient opioid prescriptions for children and opioid-related adverse events. Pediatrics. 2018, 142:10.1542\/peds.2017-2156","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1351138","article-title":"Postoperative pain control","volume":"26","author":"Garimella V","year":"2013","unstructured":"Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013, 26:191-6. 10.1055\/s-0033-1351138","journal-title":"Clin Colon Rectal Surg"},{"key":"ref10","article-title":"Intravenous Acetaminophen for the Management of Short-Term Post-Operative Pain: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet]","author":"Harricharan S","year":"2018","unstructured":"Harricharan S, Frey N. Intravenous Acetaminophen for the Management of Short-Term Post-Operative Pain: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet]. Canadian Agency for Drugs and Technologies in Health, Ottawa; 2018."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v68i3.1458","article-title":"Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making","volume":"68","author":"Jibril F","year":"2015","unstructured":"Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making. Can J Hosp Pharm. 2015, 68:238-47. 10.4212\/cjhp.v68i3.1458","journal-title":"Can J Hosp Pharm"},{"key":"ref12","unstructured":"Acetaminophen. (2018). Accessed. 2021 September 25: https:\/\/europepmc.org\/article\/nbk\/nbk482369."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-020-01147-y","article-title":"Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysis","volume":"20","author":"Carter JA","year":"2020","unstructured":"Carter JA, Black LK, Sharma D, Bhagnani T, Jahr JS. Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysis. BMC Anesthesiol. 2020, 20:272. 10.1186\/s12871-020-01147-y","journal-title":"BMC Anesthesiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01141.x","article-title":"Perioperative intravenous acetaminophen and NSAIDs","volume":"12","author":"Smith HS","year":"2011","unstructured":"Smith HS. Perioperative intravenous acetaminophen and NSAIDs. Pain Med. 2011, 12:961-81. 10.1111\/j.1526-4637.2011.01141.x","journal-title":"Pain Med"},{"key":"ref15","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs)","author":"Ghlichloo I","year":"2021","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2021 Jan-."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000674","article-title":"Ketamine for pain management","volume":"3","author":"Bell RF","year":"2018","unstructured":"Bell RF, Kalso EA. Ketamine for pain management. Pain Rep. 2018, 3:e674. 10.1097\/PR9.0000000000000674","journal-title":"Pain Rep"},{"key":"ref17","unstructured":"Ketamine hydrochloride- ketamine hydrochloride injection, solution, concentrate. (2020). Accessed. 2021 August 7: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=4485."},{"key":"ref18","article-title":"Ketamine: a review of an established yet often underappreciated medication","volume":"35","author":"Kung J","year":"2020","unstructured":"Kung J, Meisner RC, Berg S, Ellis DB. Ketamine: a review of an established yet often underappreciated medication. Newsletter J APSF. 2020, 35:33-68.","journal-title":"Newsletter J APSF"},{"key":"ref19","unstructured":"FDA approves new opioid for intravenous use in hospitals, other controlled clinical settings. (2020). Accessed. 2021 July 21: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-opioid-intravenous-use-hospitals-other-controlle...."},{"key":"ref20","unstructured":"Olinvyk (oliceridine) injection, for intravenous use, CII. (2020). Accessed. 2021 March 15: https:\/\/olinvyk.com\/docs\/OLINVYK_Label_Ver_003_Mar_2021.pdf."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S171013","article-title":"APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the \u00b5-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy","volume":"12","author":"Viscusi ER","year":"2019","unstructured":"Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N. APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the \u00b5-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy. J Pain Res. 2019, 12:927-43. 10.2147\/JPR.S171013","journal-title":"J Pain Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12801","article-title":"APOLLO-2: a randomized, placebo and active-controlled phase iii study investigating oliceridine (TRV130), a G protein-biased ligand at the \u03bc-opioid receptor, for management of moderate to severe acute pain following abdominoplasty","volume":"19","author":"Singla NK","year":"2019","unstructured":"Singla NK, Skobieranda F, Soergel DG, Salamea M, Burt DA, Demitrack MA, Viscusi ER. APOLLO-2: a randomized, placebo and active-controlled phase iii study investigating oliceridine (TRV130), a G protein-biased ligand at the \u03bc-opioid receptor, for management of moderate to severe acute pain following abdominoplasty. Pain Pract. 2019, 19:715-31. 10.1111\/papr.12801","journal-title":"Pain Pract"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer458","article-title":"Postoperative intravenous morphine titration","volume":"108","author":"Aubrun F","year":"2012","unstructured":"Aubrun F, Mazoit JX, Riou B. Postoperative intravenous morphine titration. Br J Anaesth. 2012, 108:193-201. 10.1093\/bja\/aer458","journal-title":"Br J Anaesth"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S278279","article-title":"Oliceridine: a novel drug for the management of moderate to severe acute pain - a review of current evidence","volume":"14","author":"Tan HS","year":"2021","unstructured":"Tan HS, Habib AS. Oliceridine: a novel drug for the management of moderate to severe acute pain - a review of current evidence. J Pain Res. 2021, 14:969-79. 10.2147\/JPR.S278279","journal-title":"J Pain Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-018-0106-9","article-title":"Practice patterns and treatment challenges in acute postoperative pain management: a survey of practicing physicians","volume":"7","author":"Gan TJ","year":"2018","unstructured":"Gan TJ, Epstein RS, Leone-Perkins ML, Salimi T, Iqbal SU, Whang PG. Practice patterns and treatment challenges in acute postoperative pain management: a survey of practicing physicians. Pain Ther. 2018, 7:205-16. 10.1007\/s40122-018-0106-9","journal-title":"Pain Ther"},{"key":"ref26","unstructured":"Understanding the epidemic. (2021). Accessed. 2021 August 20: https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60160-X","article-title":"Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development","volume":"386","author":"Meara JG","year":"2015","unstructured":"Meara JG, Leather AJM, Hagander L, et. al. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015, 386:569-624. 10.1016\/S0140-6736(15)60160-X","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73560-a-dive-into-oliceridine-and-its-novel-mechanism-of-action","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T18:03:46Z","timestamp":1725991426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73560-a-dive-into-oliceridine-and-its-novel-mechanism-of-action"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.19076","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}